benzenesulfonic acid has been researched along with glucagon-like peptide 1 (7-36)amide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jingu, S; Kitano, K; Kozakai, A; Mita, Y; Nakaike, S; Okumura-Kitajima, L; Tajima, A; Yamamoto, K | 1 |
1 other study(ies) available for benzenesulfonic acid and glucagon-like peptide 1 (7-36)amide
Article | Year |
---|---|
(2S,4S)-4-Fluoro-1-{[(2-hydroxy-1,1-dimethylethyl)amino]acetyl}-pyrrolidine-2-carbonitrile monobenzenesulfonate (TS-021) is a selective and reversible dipeptidyl peptidase IV inhibitor.
Topics: Administration, Oral; Animals; Benzenesulfonates; Blood Glucose; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Dogs; Glucagon-Like Peptide 1; Glucose Tolerance Test; Haplorhini; Humans; Insulin; Male; Peptide Fragments; Pyrrolidines; Rats; Substrate Specificity | 2011 |